Showing results (451-460 of 480) with videos related to
Sort By:
Pageof 48
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2009
Phase II study of eribulin mesylate, a halichondrin B analog, in patients with metastatic breast cancer previously treated with an anthracycline and a taxaneLinda T Vahdat, Brian Pruitt, Carol J Fabian, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2020
Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trialJ K Litton, S A Hurvitz, L A Mina, et al.Clinical Breast Cancer|February 14, 2008
Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriersTara M Friebel, Susan M Domchek, Susan L Neuhausen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2007
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudyStephen E Jones, James Cantrell, Svetislava Vukelja, et al.Breast Cancer Research and Treatment|January 25, 2014
Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriersJoanne Kotsopoulos, Jan Lubinski, Pal Moller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Docetaxel With Cyclophosphamide Is Associated With an Overall Survival Benefit Compared With Doxorubicin and Cyclophosphamide: 7-Year Follow-Up of US Oncology Research Trial 9735Stephen Jones, Frankie Ann Holmes, Joyce O'Shaughnessy, et al.Breast Cancer Research and Treatment|February 25, 2010
Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriersSusan M Domchek, Tara M Friebel, Judy E Garber, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2008
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective studyNoah D Kauff, Susan M Domchek, Tara M Friebel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancerStephen E Jones, Michael A Savin, Frankie Ann Holmes, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 21, 2009
Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancerNancy U Lin, Véronique Diéras, Devchand Paul, et al.Pageof 48